Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Official title: A Pilot, Safety and Clinical Activity, Phase 1b Study of DR-01 in Adults With Alopecia Areata or Vitiligo
Status: Closed to new participants
Description:
This is a multi-center, parallel-group, open-label, randomized, Phase 1b study to explore the safety, clinical activity, pharmacokinetics and pharmacodynamics of DR-01 in adults with Alopecia Areata or Vitiligo.
Phase: Phase 1.
What is being studied: drug — DR-01.
Who can take part: ages 18 Years, 81 participants planned.
Enrollment status: Closed to enrollment. The study started 30 October 2024 and is expected to finish 01 May 2027.
Source: ClinicalTrials.gov, NCT06602232 (https://clinicaltrials.gov/study/NCT06602232).
Start date: October 30, 2024
Completion date: May 01, 2027
Organizer: Dren Bio
Link: https://clinicaltrials.gov/study/NCT06602232
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...
- Why Does the IRS Still Show an Old Revocation for VR Foundation?
IRS Status · A Short FAQ The old entry records the past. Publication 78 shows where VR Foundation stands today. Updated August 2026 · EIN 45-2498489 Tax records are rarely elega...
- Will it spread?
Vitiligo is famously unpredictable, but it doesn't move at random. By looking at thousands of cases, researchers have identified specific patterns of how the condition behaves. ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.